SHELTON, CONNECTICUT / ACCESS Newswire / February 2, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...

Dana-Farber Cancer Institute-led research helped drive an FDA label update for axicabtagene ciloleucel (Yescarta) that removes a prior exclusion for patients with primary central nervous system ...

This is the 1.5 mg starter dose of Wegovy’s new weight-loss pill. Novo Nordisk said it’s suing Hims & Hers Health for making knock-offs of its obesity medicines, even as Hims scrapped plans to sell a ...

Argá Medtech today announced positive findings from a first-in-human study of its Coherent Sine-Burst Electroporation (CSE) system.

TransMedics (Nasdaq:TMDX) received FDA investigational device exemption (IDE) for its next-generation OCS ENHANCE Heart trial.

Clear Street kept a 'Buy' rating, cut its price target to $45 from $50, and said its core thesis remains intact. ・The FDA ...

According to court filings and Food and Drug Administration records, U.S. regulators have received more than 1,401 reports ...

The agency will no longer crack down on manufacturers that use natural dyes in foods labeled ‘No artificial colors.’ Here’s ...

The FDA cited uncertainty regarding the study’s eligibility criteria to define a population with neuronopathic disease versus ...

Florida’s MAHA-aligned report used EPA standards typical for soil—not food—prompting scientists to question whether its conclusions are meaningful or alarmist.

AI-enhanced surgical devices show alarming injury spikes in FDA reports, with navigation systems causing strokes and device ...